UbioLogics Reports 60.7 Billion Won Operating Profit Last Year, Up 76.8% YoY
UbioLogics announced on February 2 that its standalone operating profit for the previous year was 60.66322 billion won, a 76.8% increase compared to the previous year.
During the same period, sales reached 149.19502 billion won, marking a 55.4% increase.
Net profit for the period was tallied at 48.70392 billion won, up 156.4%.
Hot Picks Today
After Topping 8,000 Instead of Hitting 10,000... KOSPI Plunges—When Will It Rebound?
- "Samsung and Hynix Were Once for the Underachievers"... Hyundai Motor Employee's Lament
- [Breaking] Court Rules Against Samsung Electronics Union...1 Billion Won per Day Penalty for Exceeding Strike Scope
- 'Real Strike' Looms as Samsung Union Grows More Hardline... How the 2024 Strike Process Compares
- "That? It's Already Stashed" Nightlife Scene Crosses the Line [ChwiYak Nation] ③
The improved performance is attributed to an increase in the supply volume of cholera vaccines provided to UNICEF.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
